Investigational Site Number 840-122 — Waltham, Massachusetts

Investigational Site Number 840-122 is a clinical research site located in Waltham, Massachusetts, United States 02453.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840-122 has participated in 1 clinical trials.

Therapeutic areas: Type 1 Diabetes Mellitus.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Waltham

Browse all research sites in Massachusetts · View every site in Waltham

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840-122?

Investigational Site Number 840-122 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840-122 conducted?

Investigational Site Number 840-122 has 1 clinical trials on record. Their work covers Type 1 Diabetes Mellitus.

Is Investigational Site Number 840-122 accredited by Crixeo Clinical Trials?

Investigational Site Number 840-122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840-122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.